Sirion Therapeutics, Inc.

Biotech

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Study of Difluprednate in the Treatment of Uveitis

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)